💊 Health Futures #36

Happy Monday 👋

This week’s key health developments centered around vaccinations, medical devices, and practice management. In health vaccinations, after Morderna received approval for the RSV vaccine however Moderna is facing competition against GSK and Pfizer in the US market while Sanofi is meeting high demand by shipping its RSV vaccine, Beyfortus for infants. In health devices, Presto Engineering joined the MEDICALPS cluster to partner with stakeholders in the medical device industry intending to seek better challenges from the manufacturers and provide customized ASIC solutions. In practice management, Ripple Therapeutics and AbbVie entered into a collaboration to develop a next-generation drug delivery implant for the treatment of glaucoma combining Ripple's drug delivery platform with AbbVie's expertise in eye care. In health funding, Zenas BioPharma raised $225M in a Series B funding round to advance the development of evaluated for obexelimab multiple indications including IgG4-RD, MS, and SLE.

💉 Vaccinations

🦠 The World Health Organization granted its first authorization to vaccinate adults against m-pox.  The vaccine, manufactured by Bavarian Nordic, is effective in combating the disease in Africa, however, the supply is limited.

💊 Moderna faced challenges in RSV vaccines.  Moderna struggling to gain market share in RSV vaccines despite receiving FDA clearance for mResvia and the company is aiming to expand its market by targeting adults aged 18 to 59.

👶 Sanofi shipping Beyfortus for RSV prevention in infants. The drug is produced to protect infants from lower respiratory tract disease caused by RSV. Sanofi is increasing the production of the vaccines to demand for RSV.

💻 Medical Devices

🔧 Presto Engineering joined with the MEDICALPS cluster.  The partnership aimed to collaborate with key players in the medical device industry. The company aims to gain a deeper understanding of the specific challenges and needs of medical device companies and deliver customized ASIC solutions.

🩹 Alio sought expanded use for remote health monitoring devices. Alio expanded the use of its SmartPatch technology to monitor health metrics in dialysis patients without vascular access sites.

🩸 Argon Medical launched the Cleaner Vac Thrombectomy System. The system is used for the removal of blood clots from the peripheral venous vasculature. The device is currently available in the US and offers a new treatment option for patients.

🌐 Health Software Systems

🔒 RLDatix partners with Patients for Patient Safety.  The partnership will focus on enhancing patient engagement, transparency, and accountability and to reduce preventable harm in healthcare. 

📶 Kajeet partners with Avery Telehealth. The partnership aims to accelerate the deployment of digital health solutions hence enable This partnership will enable Avery Telehealth to expand its reach and offer high-quality telehealth services to a wider range of patients.

🧬 Ripple Therapeutics and AbbVie entered into a collaboration. The partnership aimed to develop RTC-620, a next-generation drug delivery implant for the treatment of glaucoma.

💰 Deals of the Week

💊 Zenas BioPharma raised $225M in a Series B funding round. The company plans to use the funds to advance the development of its lead candidate, obexelimab.

⚙️ Serán Bioscience raised $200M and plans to build a new commercial production plant. The company aims to offer a range of services, including particle engineering and finished dose forms.

🏥 Max Healthcare entered a strategic collaboration to acquire a controlling stake in Jaypee Healthcare for ~$198M. The acquisition includes Jaypee's 500-bed hospital in Noida and two other hospitals.

🧪 Cinven, a private equity firm, is selling a minority stake in Synlab, a European medical diagnostic services and specialty testing provider for $156M.

🔬 F2G, a clinical-stage biopharmaceutical company, raised $100M in funding. The company plans to use the funds to complete the late-stage development of olorofim, seek regulatory approval, and prepare for commercialization in the US.

Thank you for reading. Have a great week ahead!
Have some feedback or suggestions? Let us know at hello@holoniq.com